Arcturus Therapeutics
ARCT
ARCT
124 hedge funds and large institutions have $558M invested in Arcturus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.35% more ownership
Funds ownership: 85.46% → 87.8% (+2.3%)
6% less call options, than puts
Call options by funds: $5.38M | Put options by funds: $5.69M
Holders
124
Holding in Top 10
–
Calls
$5.38M
Puts
$5.69M
Top Buyers
| 1 | +$12.9M | |
| 2 | +$7.49M | |
| 3 | +$6.11M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.4M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.91M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$2.12M | |
| 3 | -$1.96M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.05M |
| 5 |
Jane Street
New York
|
-$863K |